AR Advanced Respiratory HUBDr. Ranjit Singh is a Pulmonologist with specialized expertise in Sleep Apnea, NIV and ILD procedures and has an experience of 18 years in this field. Having laid the foundation of his career in 2001, Dr. Singh has come a long way in terms of professional experience. His present centres of consultation are RTIICS (Kolkata) and Advanced Respiratory Centre (Jharkhand) where one may visit with a prior appointment.. He completed MBBS from Ranchi University in 1996, DM - Pulmonary Medicine from SMS Medical College, Jaipur in 2001 and MRCP from Royal Colleges of Physicians, Uk in 2008. Faculty at CMC Vellore. Trained in interventional Bronchology from France Marsille. MRCP examiner since 2012. Some of the services provided by the doctor are Video Bronchoscopy, Endobronchial Ultrasound (EBUS) and Thoracoscopy, Cryo biopsy in ILD, Debulking of the Tumor, Management of central airways Tumor, Ultrasound chest etc. Diseases like Interstitial lung diseases, Lung cancer, severe COPD, Severe Uncontrolled Asthma.
India has second highest number of obese children in world: Study
China with 15.3 million and India with 14.4 million had the highest numbers of obese children; the US with 79.4 million and China with 57.3 million had the highest numbers of obese adults in 2015.
Bronchoscopic Lung Cryobiopsy Increases Diagnostic Confidence in
the Multidisciplinary Diagnosis of Idiopathic Pulmonary Fibrosis
American Journal of Respiratory and Critical Care Medicine Volume 193 Number 7 | April 1 2016
BLC is a new biopsy method that has a meaningful
impact on diagnostic confidence in the multidisciplinary
diagnosis of interstitial lung disease and may prove useful in the
diagnosis of IPF.
Noninvasive Ventilation in Acute Hypoxemic Nonhypercapnic Respiratory Failure: A Systematic Review and Meta-Analysis
Noninvasive ventilation decreased endotracheal intubation rates and hospital mortality in acute hypoxemia nonhypercapnic respiratory failure excluding chronic obstructive pulmonary disease exacerbation and cardiogenic pulmonary edema patients. There is no sufficient scientific evidence to recommend bilevel positive airway pressure or helmet due to the limited number of trials available.
Treating asthma or COPD with steroid inhaler raises the risk of hard-to-treat infections.
These inhalers also increase the risk of lung infections caused by nontuberculous mycobacteria, which are notoriously difficult to treat and resistant to a number of common antibiotics.